Results 131 to 140 of about 17,687 (224)

INKT CELLS IN DISLIPIDEMIA.

, 2014
Natural killer T cells (NKT) are T lymphocytes with a reactivity directed against glycolipid antigens presented by MHC-like CD1d molecules expressed by antigen presenting cells (APC). A large proportion of these cells (invariant NKT cells (iNKT)) possess strong immunomodulatory properties which impose a profound impact on the development and course of ...
openaire   +1 more source

Total cholesterol and low-density lipoprotein alterations in children and adolescents from Brazil: a prevalence meta-analysis. [PDF]

Arch Endocrinol Metab, 2023
da Silva TPR, Mendes LL, Barreto VMJ, Matozinhos FP, Duarte CK.   +4 more
europepmc   +1 more source

Factores de riesgo dietético para la presencia de Dislipidemias en Escolares [PDF]

, 2013
Benítez Arciniega, Alejandra Donaji, García Abarca, Annarzhvaelig   +1 more
core  

Screening for Lysosomal Acid Lipase Deficiency in a Lipid Clinic. [PDF]

Arq Bras Cardiol
Brasil Z, Fonseca FAH, Curiati MA, Kyosen SO, Pereira VG, Fonzar WT, Pesquero JB, Patrício FRDS, Yamamoto MH, Yamamoto JU, D'Almeida V, Martins AM, Izar MC.   +12 more
europepmc   +1 more source

[Impact of COVID-19 on dyslipidemia in Ecuador]. [PDF]

Aten Primaria
Ferrés Font M, Salas R.
europepmc   +1 more source

Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025. [PDF]

Arq Bras Cardiol
Rached FH, Miname MH, Rocha VZ, Zimerman A, Cesena FHY, Sposito AC, Santos RDD, Behr PEB, Bianco HT, Alves RJ, Faludi AA, Coutinho EDR, Fonseca FAH, Carvalho LSF, Bertolami A, Rocha AMD, Marte AP, Chagas ACP, Caramelli B, Polanczyk CA, Ferreira CEDS, Serrano Junior CV, Araujo DB, Moriguchi EH, Pinto FJ, Moreira HG, Back IC, Faria Neto JR, Maia KAP, Bertolami MC, Assad MHV, Izar MCO, Barreto MA, Barreto NSF, Silva PGMBE, Pimentel Filho P, Maranhão RC, Kaiser SE, Machado VA, Saraiva JFK.   +39 more
europepmc   +1 more source

Factores asociados al Control de la Hipertensión Arterial Sistémica en Pacientes con Diabetes Mellitus tipo 2 en el Centro de Salud Emiliano Zapata, 2012. [PDF]

, 2013
Hernández Ortíz, Manuel Fermín, Pimentel Ramírez, María Luisa   +1 more
core  

Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022. [PDF]

Aten Primaria
Rivadeneira J, Fuenmayor-González L, Jácome-García M, Flores-Lastra N, Delgado H, Otzen T.   +5 more
europepmc   +1 more source

Dislipidemias, ¿qué hay de nuevo?

Revista del Hospital Italiano de Buenos Aires
En los últimos años han surgido algunas investigaciones y guías de práctica clínica relacionadas con el diagnóstico y tratamiento de las dislipidemias, que aportaron nuevos conocimientos (y controversias) sobre dicha problemática.
Walter Masson
doaj  

[Omega-3 polyunsaturated fatty acids in pediatric patients with acute lymphoblastic leukemia]. [PDF]

Rev Med Inst Mex Seguro Soc
Morales-Montes SB, Atilano-Miguel S, Barbosa-Cortés ML.   +2 more
europepmc   +1 more source